IBDEI12O ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17234,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,17235,0)
 ;;=E88.01^^88^889^2
 ;;^UTILITY(U,$J,358.3,17235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17235,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,17235,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,17235,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,17236,0)
 ;;=J09.X1^^88^889^25
 ;;^UTILITY(U,$J,358.3,17236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17236,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,17236,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,17236,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,17237,0)
 ;;=J09.X2^^88^889^26
 ;;^UTILITY(U,$J,358.3,17237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17237,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,17237,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,17237,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,17238,0)
 ;;=J09.X3^^88^889^27
 ;;^UTILITY(U,$J,358.3,17238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17238,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,17238,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,17238,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,17239,0)
 ;;=J09.X9^^88^889^28
 ;;^UTILITY(U,$J,358.3,17239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17239,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,17239,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,17239,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,17240,0)
 ;;=J44.9^^88^889^14
 ;;^UTILITY(U,$J,358.3,17240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17240,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,17240,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,17240,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,17241,0)
 ;;=J44.1^^88^889^12
 ;;^UTILITY(U,$J,358.3,17241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17241,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,17241,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,17241,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,17242,0)
 ;;=J42.^^88^889^10
 ;;^UTILITY(U,$J,358.3,17242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17242,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,17242,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,17242,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,17243,0)
 ;;=J43.9^^88^889^22
 ;;^UTILITY(U,$J,358.3,17243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17243,1,3,0)
 ;;=3^Emphysema,Unspec
 ;;^UTILITY(U,$J,358.3,17243,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,17243,2)
 ;;=^5008238
 ;;^UTILITY(U,$J,358.3,17244,0)
 ;;=J43.0^^88^889^30
 ;;^UTILITY(U,$J,358.3,17244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17244,1,3,0)
 ;;=3^MacLeod's Syndrome
 ;;^UTILITY(U,$J,358.3,17244,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,17244,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,17245,0)
 ;;=J43.1^^88^889^21
 ;;^UTILITY(U,$J,358.3,17245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17245,1,3,0)
 ;;=3^Emphysema,Panlobular
 ;;^UTILITY(U,$J,358.3,17245,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,17245,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,17246,0)
 ;;=J43.2^^88^889^19
 ;;^UTILITY(U,$J,358.3,17246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17246,1,3,0)
 ;;=3^Emphysema,Centrilobular
 ;;^UTILITY(U,$J,358.3,17246,1,4,0)
 ;;=4^J43.2
 ;;^UTILITY(U,$J,358.3,17246,2)
 ;;=^5008237
 ;;^UTILITY(U,$J,358.3,17247,0)
 ;;=J43.8^^88^889^20
